Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
01/2005
01/19/2005EP1368348B1 Novel 2,5-diazabicyclo(2.2.1)heptane derivatives
01/19/2005EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same
01/19/2005EP1140038B1 Transdermal drug delivery system
01/19/2005CN1568207A 2-amino-6-(2, 4, 5-substituted-phenyl)-pyridines
01/19/2005CN1568181A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
01/19/2005CN1566108A Red clover total flavone high content extract, preparation and application in pharmaceutical combination thereof
01/19/2005CN1566092A Indene ketone diindyl class compound, preparation method and medical use thereof
01/19/2005CN1565615A Medicine for treating impotence and aspermatism
01/19/2005CN1565614A Externally applied medicinal composition for resisting inflammation and repressing and killing bacteria and preparing method
01/19/2005CN1565612A Chinese medicinal composition for treating endometriosis and its preparing method
01/19/2005CN1565609A Chinese herbal medicine compositions and is usage
01/19/2005CN1565603A Preparing method of several Chinese herbal prescription
01/19/2005CN1565601A Application of sichuan lovage rhizome oil by supercritical CO2 extraction method in pharmacy
01/19/2005CN1565589A Abdominal mass eliminating pill
01/19/2005CN1565579A Pregnancy promoting Chinese drugs suppository
01/19/2005CN1565577A Medicinal capsule of rhubarb horsetails and granule beetle and its preparation method
01/19/2005CN1565570A Formulation for treating fetal leakage and fetal irritability and its preparing process
01/19/2005CN1565556A Chinese drugs for treating preceded menstrual cycle and excessive menses due to blood heat
01/19/2005CN1565553A Dysmenorrhea treating Chinese traditional medicine
01/19/2005CN1565550A Chinese traditional medicine for treating gynecopathy and dermatoses and preparation thereof
01/19/2005CN1565539A Chinese medicinal contraception plaster and its preparing process
01/19/2005CN1565534A Chinese traditional medicinal combination for treating putrescence of malignant disease
01/19/2005CN1565527A Medicine for treating endometriosis and its preparing process
01/19/2005CN1565516A Medicine for treating woman sterility
01/19/2005CN1565514A Chondriomere quality improving medicine and its preparing process and application
01/19/2005CN1565507A Chinese traditional medicine for treating male infertility
01/19/2005CN1565506A Chinese traditional medicine for treating female acyesis
01/19/2005CN1565496A Gynecological inflammation treating powder and its preparation
01/19/2005CN1565495A Blood circulation invigorating tablet for women and its preparation method
01/19/2005CN1565493A Blood circulation invigorating pills for women and its preparation method
01/19/2005CN1565492A Gynecopathy treating gelatin and its preparation
01/19/2005CN1565487A Gynecopathy treating pills and its preparation method
01/19/2005CN1565476A Iodine ion injection liquid
01/19/2005CN1185249C Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11
01/19/2005CN1185233C Aryl and heteroaryl diazabicycloalkanes, their preparation and use
01/19/2005CN1185229C 3-indolyl-4-phenyl-1H-pyrrole-2, 5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
01/19/2005CN1184995C Kidney-strengthening and pregnancy assisting granule
01/19/2005CN1184977C Yin nourishing and kidney reinforcing medicine
01/19/2005CN1184974C Traditional Chinese medicine compositions for treating prostatitis, impotence and ejaculation praecox
01/19/2005CN1184966C compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
01/19/2005CN1184957C Intravaginal drug delivery devices for adminsitration of testosterone and testosterone precursors
01/18/2005US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production
01/18/2005US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same
01/18/2005US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity
01/18/2005US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors
01/18/2005US6844320 Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor
01/18/2005US6844313 With protein or phosphoglyceride as aqueous solution; in vitro fertilization
01/18/2005US6843980 Methods for using annexin for detecting cell death in vivo and treating associated conditions
01/13/2005WO2005003130A1 Novel pyrrolodihydroisoquinolines useful in the treatment of cancer
01/13/2005WO2005003129A1 Pyrrolodihydroisoquinolines as pde10 inhibitors
01/13/2005WO2005002609A1 Plant extraction method and extract
01/13/2005WO2004042077A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b)
01/13/2005WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
01/13/2005US20050010047 Angiogenesis inhibitors; psoriasis; rheumatic disorders; chronic obstructive pulmonary disease
01/13/2005US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders
01/13/2005US20050009818 Therapeutic heterocyclic compounds
01/13/2005US20050009815 4-Aminoquinoline compounds
01/13/2005US20050009812 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists
01/13/2005US20050009800 Solid, free-flowing dry extract of a natural mixture of conjugated equine estrogens that has been applied by spraying an aqueous solution of the mixture onto a powdered or granular microcrystalline cellulose support that may contain lactose
01/13/2005US20050009797 Androstane derivative having substituent in 7- abd 17--positions
01/13/2005US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders
01/13/2005US20050009140 Elongase genes and uses thereof
01/13/2005US20050008611 Agent for the prevention and treatment of sexually transmitted diseases-I
01/13/2005CA2530317A1 Pyrrolodihydroisoquinolines useful in the treatment of cancer
01/13/2005CA2530316A1 Pyrrolodihydroisoquinolines as pde10 inhibitors
01/12/2005EP1495768A1 Preventives/remedies for hotflash
01/12/2005EP1495758A2 Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
01/12/2005EP1495756A1 Severe sepsis preventive therapeutic agent
01/12/2005EP1495053A2 Angiopoietin-2 specific binding agents
01/12/2005EP1495046A2 Selective melanin concentrating hormone type 1 receptor agonists
01/12/2005EP1495034A2 Mimics of acyl coenzyme-a comprising pantolactone and pantothenic acid derivatives, compositions thereof, and methods of cholesterol management and related uses
01/12/2005EP1495031A1 Labeled oxazinocarbazoles as diagnostic agents
01/12/2005EP1495030A1 Non-steroidal progesterone receptor modulators
01/12/2005EP1495023A1 Novel 1,2,3-substituted indolizine derivatives, inhibitors of fgfs, method for making same and pharmaceutical compositions containing same
01/12/2005EP1495009A2 Cyanamides useful as reversible inhibitors of cysteine proteases
01/12/2005EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents
01/12/2005EP1495004A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands
01/12/2005EP1494999A1 Occlusive composition comprising a poly(2-cyanoacrylate) monomer
01/12/2005EP1494993A2 Novel curcumin analogues and uses thereof
01/12/2005EP1494715A1 Fp receptor antagonists or pgf2 aplha antagonists for treating menorrhagia
01/12/2005EP1494713A2 Methods for treating tweak-related conditions
01/12/2005EP1494698A2 Compositions and methods for treating and preventing necrosis
01/12/2005EP1494672A1 Aminocarbonyl substituted pyridines, pyridazines, pyrimidines, pyrazines and triazines having antiangiogenic activity
01/12/2005EP1494667A1 Imidazole compounds as anti-inflammatory and analgesic agents
01/12/2005EP1494649A1 Nanoparticulate megestrol formulations
01/12/2005EP1494630A2 Bioadhesive drug delivery system
01/12/2005EP1494629A2 Condom
01/12/2005EP1353918B1 Morpholine derivatives as antagonists of orexin receptors
01/12/2005EP1313494B1 Use of a composition comprising an extract of pollen for the treatment of disease-related weight gain
01/12/2005EP1305314B1 Crystalline therapeutic agent
01/12/2005EP1286666B1 Starter kit for low dose oral contraceptives
01/12/2005EP1087773B1 Vaginal active agent delivery procedures and formulations thereof
01/12/2005EP0988860B1 Use of a-glycosylceramides for the manufacture of a therapeutic agent for autoimmune diseases
01/12/2005CN1564817A Novel benzothiazine derivatives, their preparation and use
01/12/2005CN1564689A Oral pharmaceutical products containing 17beta-estradiol-3-lower alkanoate, method of administering the same and process of preparation
01/12/2005CN1564685A Pyrrolidinone derivatives
01/12/2005CN1564676A Invert emulsion containing DHEA
01/12/2005CN1563076A Alpha-MSH analog for curing sexual disorder and preparation method
01/12/2005CN1563026A Glycoside class compound of phenethyl alcohol alcohol extracted from picria fel-terrae
01/12/2005CN1562973A New method for preparing Aripiprazole